Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4165033
Max Phase: Preclinical
Molecular Formula: C61H96N12O13
Molecular Weight: 1205.51
Molecule Type: Small molecule
Associated Items:
ID: ALA4165033
Max Phase: Preclinical
Molecular Formula: C61H96N12O13
Molecular Weight: 1205.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C61H96N12O13/c1-33(2)28-44(65-39(11)75)55(80)64-37(9)53(78)67-45(29-34(3)4)56(81)66-43(20-15-16-26-62)54(79)69-47(32-41-22-24-42(76)25-23-41)58(83)68-46(30-35(5)6)57(82)70-48(31-40-18-13-12-14-19-40)59(84)72-51(38(10)74)61(86)73-27-17-21-49(73)60(85)71-50(36(7)8)52(63)77/h12-14,18-19,22-25,33-38,43-51,74,76H,15-17,20-21,26-32,62H2,1-11H3,(H2,63,77)(H,64,80)(H,65,75)(H,66,81)(H,67,78)(H,68,83)(H,69,79)(H,70,82)(H,71,85)(H,72,84)/t37-,38+,43-,44-,45-,46-,47-,48-,49-,50-,51-/m0/s1
Standard InChI Key: BZMANSHPANHGTI-NPQPPVSJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1205.51 | Molecular Weight (Monoisotopic): 1204.7220 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
Source(1):